These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 29696499

  • 21. Fractional Anisotropy is a More Sensitive Diagnostic Biomarker Than Mean Kurtosis for Patients with Parkinson Disease with Cognitive Dysfunction: A Diffusional Kurtosis Map Tract-Based Spatial Statistics Study.
    Gao B, Qu M, Jiang Y, Li W, Wang M, Pei C, Zheng D, Yang C, Miao Y.
    AJNR Am J Neuroradiol; 2024 Aug 09; 45(8):1098-1105. PubMed ID: 38991767
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.
    Zhang Y, Wu IW, Tosun D, Foster E, Schuff N, Parkinson’s Progression Markers Initiative.
    PLoS One; 2016 Aug 09; 11(10):e0165540. PubMed ID: 27798653
    [Abstract] [Full Text] [Related]

  • 24. Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease.
    Schulz J, Pagano G, Fernández Bonfante JA, Wilson H, Politis M.
    Brain; 2018 May 01; 141(5):1501-1516. PubMed ID: 29701787
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
    Filippi M, Canu E, Donzuso G, Stojkovic T, Basaia S, Stankovic I, Tomic A, Markovic V, Petrovic I, Stefanova E, Kostic VS, Agosta F.
    Mov Disord; 2020 Nov 01; 35(11):1987-1998. PubMed ID: 32886420
    [Abstract] [Full Text] [Related]

  • 28. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
    Ray NJ, Bradburn S, Murgatroyd C, Toseeb U, Mir P, Kountouriotis GK, Teipel SJ, Grothe MJ.
    Brain; 2018 Jan 01; 141(1):165-176. PubMed ID: 29228203
    [Abstract] [Full Text] [Related]

  • 29. Influence of depression in mild Parkinson's disease on longitudinal motor and cognitive function.
    Ng A, Chander RJ, Tan LC, Kandiah N.
    Parkinsonism Relat Disord; 2015 Sep 01; 21(9):1056-60. PubMed ID: 26117438
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. White matter integrity and cognition in Parkinson's disease: a cross-sectional study.
    Auning E, Kjærvik VK, Selnes P, Aarsland D, Haram A, Bjørnerud A, Hessen E, Esnaashari A, Fladby T.
    BMJ Open; 2014 Jan 21; 4(1):e003976. PubMed ID: 24448846
    [Abstract] [Full Text] [Related]

  • 32. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.
    Mak E, Dwyer MG, Ramasamy DP, Au WL, Tan LC, Zivadinov R, Kandiah N.
    J Neuroimaging; 2015 Jan 21; 25(5):754-60. PubMed ID: 25753576
    [Abstract] [Full Text] [Related]

  • 33. Microstructural abnormalities of substantia nigra in Parkinson's disease: A neuromelanin sensitive MRI atlas based study.
    Safai A, Prasad S, Chougule T, Saini J, Pal PK, Ingalhalikar M.
    Hum Brain Mapp; 2020 Apr 01; 41(5):1323-1333. PubMed ID: 31778276
    [Abstract] [Full Text] [Related]

  • 34. Changes of olfactory tract in Parkinson's disease: a DTI tractography study.
    Nigro P, Chiappiniello A, Simoni S, Paolini Paoletti F, Cappelletti G, Chiarini P, Filidei M, Eusebi P, Guercini G, Santangelo V, Tarducci R, Calabresi P, Parnetti L, Tambasco N.
    Neuroradiology; 2021 Feb 01; 63(2):235-242. PubMed ID: 32918150
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra.
    Joshi N, Rolheiser TM, Fisk JD, McKelvey JR, Schoffer K, Phillips G, Armstrong M, Khan MN, Leslie RA, Rusak B, Robertson HA, Good KP.
    J Neurol; 2017 Jul 01; 264(7):1497-1505. PubMed ID: 28653210
    [Abstract] [Full Text] [Related]

  • 37. In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: Imaging results from the COPPADIS study.
    Grothe MJ, Labrador-Espinosa MA, Jesús S, Macías-García D, Adarmes-Gómez A, Carrillo F, Camacho EI, Franco-Rosado P, Lora FR, Martín-Rodríguez JF, Barberá MA, Pastor P, Arroyo SE, Vila BS, Foraster AC, Martínez JR, Padilla FC, Morlans MP, Aramburu IG, Ceberio JI, Vara JH, de Fábregues-Boixar O, de Deus Fonticoba T, Pascual-Sedano B, COPPADIS Study Group, Kulisevsky J, Martínez-Martín P, Santos-García D, Mir P.
    Parkinsonism Relat Disord; 2021 Jul 01; 88():68-75. PubMed ID: 34144230
    [Abstract] [Full Text] [Related]

  • 38. Local white matter abnormalities in Parkinson's disease with mild cognitive impairment: Assessed with neurite orientation dispersion and density imaging.
    Zhang C, Yuan Y, Sang T, Yu L, Yu Y, Liu X, Zhou W, Zeng Q, Wang J, Peng G, Feng Y.
    J Neurosci Res; 2023 Jul 01; 101(7):1154-1169. PubMed ID: 36854050
    [Abstract] [Full Text] [Related]

  • 39. Subcortical microstructural diffusion changes correlate with gait impairment in Parkinson's disease.
    Surkont J, Joza S, Camicioli R, Martin WRW, Wieler M, Ba F.
    Parkinsonism Relat Disord; 2021 Jun 01; 87():111-118. PubMed ID: 34020302
    [Abstract] [Full Text] [Related]

  • 40. Tract-Based Spatial Statistics Reveal Lower White Matter Integrity Specific to Idiopathic Rapid Eye Movement Sleep Behavior Disorder as a Proxy for Prodromal Parkinson's Disease.
    Ohlhauser L, Smart CM, Gawryluk JR.
    J Parkinsons Dis; 2019 Jun 01; 9(4):723-731. PubMed ID: 31498130
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.